High manufacturing, quality, and safety standards are the basis for the successful activities of Petrovax. For over 25 years, the Company has been involved in the development and manufacture of efficacious and safe innovative medical products and vaccines for the benefit of human health and improvement of living standards.
The Company’s manufacturing complex in the Moscow region is one of the most advanced and high-tech biopharmaceutical facilities in Russia. The Company’s manufacturing facilities fully comply with current Russian and international Good Manufacturing Practice (GMP) and ISO 9001 standards.
Petrovax is one of the first Russian manufacturers holding GMP certificates issued by the European, Iranian, and Russian authorities.
Perfect aseptic conditions, clear area zoning, and automated product manufacturing are the fundamentals of pharmaceutical facility operations. The actions of each employee can be monitored and assessed in real time. Qualification of all utility systems and the full range of validation activities (from clean rooms to manufacturing and packaging processes) are performed on an annual basis. Raw and other materials are only delivered by approved suppliers.
All Petrovax products go through a full life cycle from molecule development to finished dosage form. Preclinical and clinical trials of drug products are conducted in strict adherence to applicable legislative acts, Russian and international requirements. Quality control of manufactured medicinal products and vaccines is provided at all stages from raw material sampling to finished product control.
The Company has been operating a Quality Management System for many years, which is confirmed with the ISO: 9001 Certificate. Petrovax is a member of the Drug Labeling project, whose main goal is to exclude illegal and low-quality products from circulation.
Since 2019, the Company has been running the Green Committee, whose members support the conscious consumption of resources and introduce ecotechnologies to create a favorable working environment.
In 2021, Petrovax starts implementation of the project in sustainable development in cooperation with Schneider Electric, the global leader in the digital transformation of energy management and automation. Schneider Electric’s innovative energy-saving technologies will improve the profitability and environmental friendliness of all manufacturing processes at the Petrovax facility. The project involves the installation of the second transformer substation and a gas-piston thermal power plant.
High manufacturing standards allow the implementation of international projects and the transfer of the full-cycle production technology to Russia. Therefore, such world leaders as Pfizer, Abbott, Boehringer Ingelheim, and many others cooperate and launch joint projects with Petrovax.